George Eisenbarth professeur d'université américain
Eisenbarth, George S.
Eisenbarth, G. S.
Eisenbarth, George S., endocrinologue
Eisenbarth, George S. 1947-2012
VIAF ID: 94545190 (Personal)
Permalink: http://viaf.org/viaf/94545190
Preferred Forms
- 200 _ | ‡a Eisenbarth ‡b George S.
- 100 1 _ ‡a Eisenbarth, G. S.
-
- 100 1 _ ‡a Eisenbarth, George S.
- 100 1 _ ‡a Eisenbarth, George S.
-
-
-
-
-
-
- 100 1 _ ‡a Eisenbarth, George S. ‡d 1947-2012
- 100 1 _ ‡a Eisenbarth, George S., ‡c endocrinologue
- 100 0 _ ‡a George Eisenbarth ‡c professeur d'université américain
4xx's: Alternate Name Forms (10)
Works
Title | Sources |
---|---|
Endocrine and organ specific autoimmunity | |
Immunoendocrinology : scientific and clinical aspects | |
Immunology of type one diabetes | |
Immunotherapy of diabetes and selected autoimmune diseases, 1989: | |
Monoclonal antibodies in endocrine research, c1981 (a.e.) | |
Monoclonal antibodies, probes for the study of autoimmunity and immunodeficiency | |
Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes | |
Pancreatic autoimmunity induction with insulin B:9-23 peptide and viral mimics in the NZB mouse | |
Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells | |
The paternally inherited insulin gene B allele (1,428 FokI site) confers protection from insulin-dependent diabetes in families | |
Perinatal factors and development of islet autoimmunity in early childhood: the diabetes autoimmunity study in the young | |
The potentially simple mathematics of type I diabetes | |
Pre-hyperglycemic diabetes mellitus | |
The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients | |
Preventing peptide-induced anaphylaxis: addition of C-terminal amino acids to produce a neutral isoelectric point | |
Production of insulin antibodies by mice rejecting insulin transfected cells | |
Production of monoclonal antibodies reacting with peripheral blood mononuclear cell surface differentiation antigens | |
Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes | |
Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors | |
Progressive autoimmune beta cell insufficiency: occurrence in the absence of high-risk HLA alleles DR3, DR4 | |
Prolonged sera incubation to improve sensitivity of double-immunofluorescent monoclonal BISL-32 FITC-protein A assay | |
Prospective analysis suggests susceptibility genes for deficiencies of IgA and several other immunoglobulins on the [HLA-B8, SC01, DR3] conserved extended haplotype | |
Prospective study of enteroviral infections and development of beta-cell autoimmunity | |
Prostaglandin inhibition of cartilage chondromucoprotein synthesis: concept of "intrinsic activity" | |
Protein tyrosine phosphatase-like proteins: link with IDDM. | |
Reanalysis of twin studies suggests that diabetes is mainly genetic | |
Relationship between protein complotypes and DNA variant haplotypes: complotype-RFLP constellations | |
Replication and further characterization of a Type 1 diabetes-associated locus at the telomeric end of the major histocompatibility complex | |
Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study. | |
Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease | |
Rituximab selectively suppresses specific islet antibodies | |
The role of late-onset autoimmune diabetes in white familial NIDDM pedigrees | |
Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study | |
rs2476601 T allele (R620W) defines high-risk PTPN22 type I diabetes-associated haplotypes with preliminary evidence for an additional protective haplotype | |
Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes | |
Selective localization of factor VIII antigenicity to islet endothelial cells and expression of class II antigens by normal human pancreatic ductal epithelium | |
Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs | |
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children | |
Sexual dimorphism in transmission of expression of islet autoantibodies to offspring. | |
Single nucleotide polymorphism study of IDDM 17 in a Bedouin Arab family | |
Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in antiislet autoantibody-negative patients at onset of diabetes | |
Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes | |
The stages of type 1A diabetes: 2005. | |
Standardization of IVGTT to predict IDDM | |
Stimulation of cartilage amino acid uptake by growth hormone-dependent factors in serum. Mediation by adenosine 3':5'-monophosphate | |
Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation | |
T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects | |
T cell receptor restriction of diabetogenic autoimmune NOD T cells | |
Timing of initial exposure to cereal grains and the risk of wheat allergy | |
Transfer plate radioassay using adsorbed anti-insulin antibody to detect insulin secreted by islet cell cultures | |
Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout | |
Transgenic mouse models of type I diabetes | |
Transglutaminase antibodies in children with a genetic risk for celiac disease | |
Transient antiislet autoantibodies: infrequent occurrence and lack of association with "genetic" risk factors | |
Transient insulin autoantibody expression independent of development of diabetes: comparison of NOD and NOR strains | |
Translating mucosal antigen based prevention of autoimmune diabetes to human. | |
Transmission of DQ haplotypes to patients with type 1 diabetes | |
Trials of immunotherapy to preserve beta-cell function of prediabetic and new-onset patient trials. | |
Triple chimeric islet autoantigen IA2-ZnT8WR to facilitate islet autoantibody determination | |
Type 1 diabetes mellitus of man: genetic susceptibility and resistance. | |
Type 1 diabetes: primary antigen/peptide/register/trimolecular complex | |
Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. | |
Type I diabetes mellitus: lessons for human autoimmunity | |
Type I diabetes: polygenic inheritance, multiple autoantigens and 'dual' parameter prediction | |
Update in type 1 diabetes | |
Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes | |
Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies | |
γδ T cells recognize the insulin B:9-23 peptide antigen when it is dimerized through thiol oxidation. |